Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omnichem, now operating as Ajinomoto Bio-Pharma Services, is a prominent European contract development and manufacturing organization (CDMO) based in Belgium. The company gained historical notoriety in the life sciences sector as the "unnamed European manufacturer" that produced a significant 44 kg batch of high-purity iboga extract in 1981, which was subsequently used in pioneering addiction treatment efforts in Denmark. Today, the company provides a wide range of manufacturing services for small molecules and biologics, including high-potency active pharmaceutical ingredients (APIs) and advanced intermediates. It serves global pharmaceutical and biotech clients by offering process development, scale-up, and commercial-scale production under cGMP standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unnamed European manufacturer.